share_log

Truist Securities Initiates Coverage On Insmed With Buy Rating, Announces Price Target of $48

Truist Securities Initiates Coverage On Insmed With Buy Rating, Announces Price Target of $48

Truist Securities以买入评级启动对Insmed的报道,宣布目标股价为48美元
Moomoo 24/7 ·  04/23 06:40

Truist Securities analyst Nicole Germino initiates coverage on Insmed (NASDAQ:INSM) with a Buy rating and announces Price Target of $48.

Truist Securities分析师妮可·杰尔米诺以买入评级启动了对Insmed(纳斯达克股票代码:INSM)的报道,并宣布目标股价为48美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发